Entera Bio (ENTX) EPS (Basic) (QoQ) (2021 - 2026)
Entera Bio (ENTX) EPS (Basic) (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | Entera Bio | 165.98 Mn | 154.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.16% |
| Mar 31, 2026 | -11.30% |
| Dec 31, 2025 | 6.79% |
| Sep 30, 2025 | -24.95% |
| Jun 30, 2025 | 3.39% |
| Mar 31, 2025 | 3.60% |
| Dec 31, 2024 | 21.96% |
| Sep 30, 2024 | -22.24% |
| Jun 30, 2024 | -16.96% |
| Mar 31, 2024 | 18.38% |
| Dec 31, 2023 | 16.70% |
| Sep 30, 2023 | -2.32% |
| Jun 30, 2023 | -6.16% |
| Mar 31, 2023 | 27.85% |
| Dec 31, 2022 | 1.04% |
| Sep 30, 2022 | 3.71% |
| Jun 30, 2022 | 15.84% |
| Mar 31, 2022 | 16.26% |
| Dec 31, 2021 | -40.00% |
| Sep 30, 2021 | -7.48% |